NorthX Biologics welcomes Dr Janet Hoogstraate as new CEO following merger with Valneva Clinical Trials Manufacturing unit
We are announcing the appointment of a new CEO Dr. Janet Hoogstraate. Janet is a distinguished leader within the biopharmaceutical sector and this move follows the company’s strategic merger with Valneva ...
NorthX Biologics acquires the Stockholm-based Clinical Trial Manufacturing unit from Valneva Sweden
NorthX Biologics, a leading Nordic development and manufacturing organisation announces acquisition of a biologics manufacturing unit from Valneva MATFORS, Sweden, July 03, 2023 (GLOBE NEWSWIRE) NorthX Biologics (‘NorthX’), a leading ...
Covid-19 vaccine that can cope with mutated viruses in clinical phase 1 study at Karolinska University Hospital
A new DNA-based vaccine against covid-19 is being tested for the first time on healthy participants at Karolinska University Hospital. The vaccine has been developed at Karolinska Institutet and target ...
Mendus and NorthX Biologics to enter into strategic cell therapy manufacturing alliance supported by new investor Flerie
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it has entered into a manufacturing alliance with NorthX Biologics AB (“NorthX”). NorthX ...
NorthX Biologics enters as a partner in AdBIOPRO, Competence Centre for Advanced BioProduction
NorthX Biologics is proud to have the opportunity to support and be a part of AdBIOPRO. “It is a great infrastructure for ground breaking research and development aimed at finding ...
The factory in Matfors aims to become a magnet for development work!
Now you can read the exciting article about the innovation factory on Dagens Industri. The digital link can be found here!
New rating for NorthX Biologics in International Sustainability Survey
We are proud to inform you that NorthX Biologics improved its score from bronze to silver in the International Sustainability Survey (EcoVadis) for the year 2022. We have also implemented ...
Advanced Biologics in Matfors and Beyond
Conference “Advanced Biologics in Matfors and Beyond” at NorthX Bio went to a big success! During a two day conference, a number of key stakeholders from the Swedish and Danish ...
Xintela and NorthX Biologics sign framework agreement for collaboration
Xintela and NorthX Biologics announce that they have signed a collaborative framework agreement to jointly accelerate the development of advanced therapeutics (ATMP) by leveraging the companies’ complementary skills and resources ...